The store will not work correctly when cookies are disabled.
Methyl (E)-4-((2-(3-(trifluoromethyl)phenyl)vinyl)sulfonamido)benzoate
ID: ALA4551433
PubChem CID: 155555311
Max Phase: Preclinical
Molecular Formula: C17H14F3NO4S
Molecular Weight: 385.36
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: COC(=O)c1ccc(NS(=O)(=O)/C=C/c2cccc(C(F)(F)F)c2)cc1
Standard InChI: InChI=1S/C17H14F3NO4S/c1-25-16(22)13-5-7-15(8-6-13)21-26(23,24)10-9-12-3-2-4-14(11-12)17(18,19)20/h2-11,21H,1H3/b10-9+
Standard InChI Key: FBRUJXNFZXXUCQ-MDZDMXLPSA-N
Molfile:
RDKit 2D
26 27 0 0 0 0 0 0 0 0999 V2000
26.6908 -1.9976 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
27.1035 -2.7075 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
27.5119 -1.9951 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
23.5692 -3.1284 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.5680 -3.9479 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.2761 -4.3569 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.9857 -3.9475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.9829 -3.1248 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.2743 -2.7195 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.6891 -2.7135 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.3983 -3.1195 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.8137 -3.1141 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.8614 -2.7200 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.8612 -1.9028 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
22.1538 -3.1287 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
22.1508 -2.3112 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
28.5200 -2.7030 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.2250 -3.1108 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.9307 -2.7004 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.9283 -1.8823 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.2141 -1.4764 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.5113 -1.8892 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.6340 -1.4703 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.3437 -1.8754 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
31.3477 -2.6926 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.6300 -0.6531 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 4 1 0
8 10 1 0
10 11 2 0
11 2 1 0
2 12 1 0
4 13 1 0
13 14 1 0
13 15 1 0
13 16 1 0
12 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 17 1 0
20 23 1 0
23 24 1 0
24 25 1 0
23 26 2 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 385.36 | Molecular Weight (Monoisotopic): 385.0596 | AlogP: 3.90 | #Rotatable Bonds: 5 |
Polar Surface Area: 72.47 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 8.78 | CX Basic pKa: ┄ | CX LogP: 3.56 | CX LogD: 3.55 |
Aromatic Rings: 2 | Heavy Atoms: 26 | QED Weighted: 0.79 | Np Likeness Score: -1.31 |
References
1. Sabbah M, Mendes V, Vistal RG, Dias DMG, Záhorszká M, Mikušová K, Korduláková J, Coyne AG, Blundell TL, Abell C.. (2020) Fragment-Based Design of Mycobacterium tuberculosis InhA Inhibitors., 63 (9): [PMID:32240584] [10.1021/acs.jmedchem.0c00007] |